Pefkianaki Maria, Agrawal Rupesh, Desai Parul, Pavesio Carlos, Sagoo Mandeep S
Moorfields Eye Hospital, City Road, London, EC1V 2PD, UK.
Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
BMC Cancer. 2015 Jan 30;15:23. doi: 10.1186/s12885-015-1020-8.
Bilateral diffuse uveal melanocytic proliferation (BDUMP) is a paraneoplastic ocular syndrome occurring in patients with systemic, often occult but advanced carcinoma and is the hallmark of poor prognosis. Ocular signs precede manifestation of systemic carcinoma by 3-12 months, highlighting the need for appropriate index of suspicion and prompt evaluation. Treatment options for BDUMP are limited. Investigations are aimed at finding the occult primary malignancy, which can be challenging. Modalities for treatment of the ocular findings include corticosteroids, surgery, external beam radiotherapy, and treatment of the underlying malignant neoplasm. However, it is uncertain whether earlier intervention for the systemic malignancy will impact survival, as this paraneoplastic phenomenon is thought to occur in advanced malignancy.
We report a unique rare atypical case with BDUMP causing visual loss in a 62-year-old female as the presenting sign of central nervous system (CNS) B-cell lymphoma. Multiple grey or grey brown subretinal lesions with pigment clumps were present in both eyes on fundoscopy and multimodal imaging demonstrated multiple discrete lesions at the level of retinal pigment epithelium. Neuroimaging revealed presence of brainstem and cerebellopontine lesions suggestive of CNS lymphoma, which was further confirmed on biopsy.
In the current atypical case, prompt diagnosis and immediate referral was key, with detailed systemic evaluation by an internist and oncologist. The reported case is distinct for the reason that BDUMP occurred secondary to primary CNS lymphoma, a hitherto unreported association.
双侧弥漫性葡萄膜黑素细胞增生(BDUMP)是一种副肿瘤性眼部综合征,发生于患有全身性、通常隐匿但已进展的癌症患者中,是预后不良的标志。眼部体征先于全身性癌症出现3 - 12个月,这突出了需要有适当的怀疑指标并及时进行评估。BDUMP的治疗选择有限。检查旨在发现隐匿的原发性恶性肿瘤,这可能具有挑战性。治疗眼部表现的方式包括使用皮质类固醇、手术、外照射放疗以及治疗潜在的恶性肿瘤。然而,对于全身性恶性肿瘤的早期干预是否会影响生存尚不确定,因为这种副肿瘤现象被认为发生于晚期恶性肿瘤。
我们报告了一例独特罕见的非典型病例,一名62岁女性因BDUMP导致视力丧失,这是中枢神经系统(CNS)B细胞淋巴瘤的首发症状。眼底检查时双眼可见多个灰色或灰棕色视网膜下病变伴色素团块,多模态成像显示视网膜色素上皮层有多个离散病变。神经影像学检查显示脑干和小脑桥脑病变,提示CNS淋巴瘤,活检进一步证实。
在当前这例非典型病例中,及时诊断和立即转诊是关键,由内科医生和肿瘤学家进行详细的全身评估。所报告的病例独特之处在于BDUMP继发于原发性CNS淋巴瘤,这是一种迄今未报告过的关联。